Julia Ohrndorf

Computer‐Assisted Selective Optimization of Side‐Activities—from Cinalukast to a PPARα Modulator

D. Merk, A. Kaiser, Julius Pollinger, 2019, ChemMedChem.

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries

E. Proschak, D. Merk, J. Heering, 2022, ChemMedChem.

A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences.

S. Knapp, A. Chaikuad, D. Merk, 2019, ACS medicinal chemistry letters.

Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.

E. Proschak, D. Merk, J. Heering, 2019, Journal of medicinal chemistry.

Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype.

E. Proschak, D. Merk, Pascal Heitel, 2019, ACS medicinal chemistry letters.

Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms.

D. Merk, J. Heering, Whitney Kilu, 2021, Journal of Medicinal Chemistry.